Investigation Overview
An investigation on behalf of investors in XenoPort, Inc. (NASDAQ:XNPT) common stock, including those who purchased XNPT stock between May 5, 2009 and February 17, 2010, over possible violations of Federal Securities Laws was announced. XenoPort, Inc., located in Santa Clara, California, is a biopharmaceutical company focused on developing and commercializing a portfolio of internall...
You must register (for free) or login to view the entire investigation.